Ryan Specialty Q3 revenue up 21.8% to $502M; adj. diluted EPS $0.32 beats prior year

RYAN SPECIALTY HOLDINGS, INC.

Total revenue $501.9M, up 21.8% YoY; organic growth rate 14.7%.
Net income $15.7M vs $29.3M YoY; GAAP diluted loss per share $(0.04) due to discrete deferred tax expense.
Adjusted EBITDAC $147.0M, up 25.8%; margin expanded to 29.3% from 28.4%.
Adjusted net income $86.6M, up 30.2%; adjusted diluted EPS $0.32, up 28.0%.
Agreed to acquire AccuRisk to expand benefits practice; three acquisitions closed in July 2023.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

RYAN SPECIALTY HOLDINGS, INC. reported third quarter ended September 30, 2023 results: revenue $501.9 million, net income $15.7 million, EPS $(0.04) per diluted share.

Period: third quarter ended September 30, 2023
Revenue: $501.9 million
Net income: $15.7 million
EPS: $(0.04) per diluted share
Result: reported results

Exact text from the filing

forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 RYAN SPECIALTY REPORTS THIRD QUARTER 2023 RESULTS - Total Revenue grew 21.8% year-over-year to $501.9 million - - Organic Revenue Growth Rate of 14.7% year-over-year - - Net Income of $15.7 million, or $(0.04) per diluted share 1 - - Adjusted EBITDAC grew 25.8% year-over-year to $147.0

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

RYAN SPECIALTY HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-058239

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.